Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manish Narang

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
The Lancet Regional Health. Southeast Asia|August 1, 2025
Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among individuals aged 5-80 years in India: a phase 3, single-blind, randomised controlled trialSubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
The Lancet Regional Health. Southeast Asia|March 11, 2026
Immunogenicity and safety of biological E's 14-valent pneumococcal conjugate vaccine (PNEUBEVAX 14®) administered in a 2p + 1 schedule to healthy infants: a multicenter, randomized, active controlled, single-blind, phase III trialSubhash Thuluva, Ramesh V Matur, Subbareddy Gunneri, et al.
Asiaintervention|March 20, 2023
Clinical use of optical coherence tomography during percutaneous coronary intervention and coronary procedures in Southeast Asia: a survey-based expert consensus summaryAdrian F Low, Nattawut Wongpraparut, Narathip Chunhamaneewat, et al.
Scientific Reports|December 6, 2025
Real-world study to compare functional SYNTAX score versus anatomical SYNTAX score in influencing the treatment strategy for multivessel disease patientsNattawut Wongpraparut, Sivakumar Rathnavel, Mann Chandavimol, et al.
Indian Heart Journal|May 27, 2023
Effectiveness and safety of optical coherence tomography-guided PCI in Indian patients with complex lesions: A multicenter, prospective registryPraveen Chandra, Selvamani Sethuraman, Sanjeeb Roy, et al.
Vaccine|November 3, 2022
Safety, tolerability and immunogenicity of Biological E's CORBEVAX™ vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 studySubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
Vaccines|June 25, 2026
Safety, Immunogenicity of Co-Administered Vaccines, and Lot-to-Lot Consistency of a 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14<sup>®</sup>) Administered at 6-10-14 Weeks in Healthy Infants: A Multicenter, Phase IV TrialSubhash Thuluva, Subbareddy Gunneri, Siddalingaiah Ningaiah, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
The Lancet Regional Health. Southeast Asia|August 1, 2025
Safety and immunogenicity of booster doses of an XBB.1.5 RBD subunit COVID-19 vaccine among individuals aged 5-80 years in India: a phase 3, single-blind, randomised controlled trialSubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
The Lancet Regional Health. Southeast Asia|March 11, 2026
Immunogenicity and safety of biological E's 14-valent pneumococcal conjugate vaccine (PNEUBEVAX 14®) administered in a 2p + 1 schedule to healthy infants: a multicenter, randomized, active controlled, single-blind, phase III trialSubhash Thuluva, Ramesh V Matur, Subbareddy Gunneri, et al.
Asiaintervention|March 20, 2023
Clinical use of optical coherence tomography during percutaneous coronary intervention and coronary procedures in Southeast Asia: a survey-based expert consensus summaryAdrian F Low, Nattawut Wongpraparut, Narathip Chunhamaneewat, et al.
Scientific Reports|December 6, 2025
Real-world study to compare functional SYNTAX score versus anatomical SYNTAX score in influencing the treatment strategy for multivessel disease patientsNattawut Wongpraparut, Sivakumar Rathnavel, Mann Chandavimol, et al.
Indian Heart Journal|May 27, 2023
Effectiveness and safety of optical coherence tomography-guided PCI in Indian patients with complex lesions: A multicenter, prospective registryPraveen Chandra, Selvamani Sethuraman, Sanjeeb Roy, et al.
Vaccine|November 3, 2022
Safety, tolerability and immunogenicity of Biological E's CORBEVAX™ vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 studySubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
Vaccines|June 25, 2026
Safety, Immunogenicity of Co-Administered Vaccines, and Lot-to-Lot Consistency of a 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14<sup>®</sup>) Administered at 6-10-14 Weeks in Healthy Infants: A Multicenter, Phase IV TrialSubhash Thuluva, Subbareddy Gunneri, Siddalingaiah Ningaiah, et al.
Pageof 6